Navigation Links
Independent panel to present findings on diagnosing gestational diabetes mellitus
Date:2/20/2013

What:

Gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy (especially during the third trimester of pregnancy). It is defined as carbohydrate intolerance, which is the inability of the body to adequately process carbohydrates (sugars and starches) into energy for the body, that develops or is first recognized during pregnancy. GDM is estimated to occur in 1 to 14 percent of U.S. pregnancies, affecting more than 200,000 women annually. It is one of the most common disorders in pregnancy and is associated with an increased risk of complications for the mother and child. Potential complications during pregnancy and delivery include preeclampsia (high blood pressure and excess protein in the urine), cesarean delivery, macrosomia (large birth weight), shoulder dystocia (when a baby's shoulders become lodged during delivery), and birth injuries. For the neonate, complications include difficulty breathing at birth, hypoglycemia (low blood sugar), and jaundice. Up to one-half of women who have GDM during pregnancy will develop type 2 diabetes later in life.

Although the U.S. Preventive Services Task Force found in 2008 that the evidence was insufficient to assess the balance between the benefits and harms of screening women for GDM, the American College of Obstetricians and Gynecologists recommends universal screening for gestational diabetes using patient history, risk factors, or laboratory testing, such as with a glucose challenge test (GCT). Different approaches are used internationally for screening and diagnosis of GDM. Debate continues regarding the choice of tests and the effectiveness of treatment, especially in women with mild to moderate glucose intolerance.

To better understand the benefits and risks of various GDM diagnostic approaches, the National Institutes of Health is convening a Consensus Development Conference March 4-6, 2013 to assess the available scientific evidence. An impartial, independent panel will hold a press telebriefing after the conference to discuss their findings and implications for the public. The panel's statement will incorporate their assessment of the available evidence from a systematic literature review, expert presentations, and audience input to inform public and provider decisions regarding diagnosing gestational diabetes mellitus. Additional information about the NIH Consensus Development Conference: Diagnosing Diabetes Mellitus is available at http://prevention.nih.gov/cdp/conferences/2013/gdm/default.aspx.

Who, When & Where:

Members of the Consensus Development Panel, to be announced Monday, March 4, 2013.

Presentation and discussion of the panel's draft statement:

  • Wednesday, March 6, 2013 at 9 a.m. EST
  • Natcher Conference Center on the main NIH campus in Bethesda, Md.
  • Also available via live webcast: http://videocast.nih.gov/

Press Telebriefing: Presentation and discussion of the panel's draft statement:

Please call in 5 to 10 minutes prior to the start of the telebriefing. Media will be asked for name and outlet. Interested parties who are not affiliated with a media outlet may listen in, but will not be permitted to ask questions during the call.

Conference Information: The Consensus Development Conference is free and open to the public. Conference times are listed below and further details are available at http://prevention.nih.gov/cdp/conferences/2013/gdm/default.aspx.

  • Monday, March 4, 2013 - 8:30 a.m. - 5 p.m.
  • Tuesday, March 5, 2013 - 8:30 a.m. - 11 a.m.
  • Wednesday, March 6, 2013 - 9 a.m. - 11 a.m.

Live and archived webcast: http://videocast.nih.gov/


'/>"/>

Contact: Deborah Langer
langerdh@od.nih.gov
NIH/Office of Disease Prevention
Source:Eurekalert

Related medicine news :

1. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
2. MyTownInsurance.com Reveals How Project CAP and Insurance Agoragate will Take Away Market Share from the Captive Insurance Carriers and give it back to the Independents
3. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
4. Helping Alzheimers patients stay independent
5. Independent Care to Open New Office with Service Area Expansion
6. Funding Meals on Wheels Keeps Seniors Independent: Study
7. Study shows COPD is not independent risk factor for lung cancer
8. Omega XL Reports New Independent Study:Omega-3s Help Heal Bedsores In Critically Ill
9. Independent Research Shows That Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Continues to Achieve Exceptional Scores in Customer Satisfaction
10. Yumi Media Encourages Vegetarianism For Heart Health As Reported In the Independent Florida Alligator
11. Liproxenol is First Diet Pill to Earn Perfect Score from Independent Review Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ALEXANDRIA, VA (PRWEB) , ... February 20, 2017 , ... ... with Cambridge Healthcare to open and operate a state-of-the-art memory care community in Alexandria, ... of 2018 on a site just outside of Old Town. , The three-story ...
(Date:2/20/2017)... ... 2017 , ... Researchers at the University of Pittsburgh School of Medicine have ... may predict response to a particular class of drugs, not just in patients with ... new findings were published in Proceedings of the National Academy of Science. , “These ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, Biscom , the ... the first IoT device from Biscom designed to deliver confidential patient information securely ... at HIMSS17 and will be conducting demonstrations at Booth #374. ...
(Date:2/20/2017)... ... ... a Population Health Software Company, is pleased to announce a move to a larger office ... the size of the previous location while bringing life back to a medical practice building ... are excited to expand our footprint to better serve our growing client base. We ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and Center ... a joint event at Chuck E. Cheese’s locations throughout New England, New York and ... the opportunity to experience the fun of visiting Chuck E. Cheese’s in a sensory-friendly ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... EU5 Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 ... ... Outlook to 2022", provides key market data on the EU5 Magnetic ... of US dollars, volume (in units) and average prices (USD) within ... The report also provides company shares and distribution shares ...
(Date:2/20/2017)... 2017 Taiwan Biophotonic Co. (tBPC), a medical ... signs sensing solutions, today announced the CE Marking and ... oximeter, the oCare TM Pro 100, which is a ... devices space.  tBPC,s Wrist Pulse Oximeter, the ... and reliable method to measure and record heart rate ...
(Date:2/20/2017)... TEMPE, Ariz. , Feb. 20, 2017 /PRNewswire/ ... to the medical device industry, announced today that ... Vention Medical,s Device Manufacturing Services business.  ... bolsters its position as a leading services provider ... MedPlast,s acquisition will further expand the company,s ...
Breaking Medicine Technology: